536127428	536127428	CD	B-NP	O
|	|	NN	I-NP	O
MAAH	MAAH	NN	I-NP	O
|	|	NN	I-NP	O
05601140	05601140	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8905957	8905957	CD	B-NP	O
|	|	CC	I-NP	O
12/10/2005	12/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NNP	I-NP	I-protein
,	,	,	O	O
URI	URI	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
12/10/2005	12/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/20/2005	4/20/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	B-protein
KOVALCHIK	KOVALCHIK	NNP	B-NP	I-protein
,	,	,	O	O
JUDE	JUDE	NNP	B-NP	O
D.	D.	NNP	I-NP	O
045-43-50-4	045-43-50-4	CD	I-NP	O
Burb	Burb	NNP	I-NP	O
,	,	,	I-NP	O
Kansas	Kansas	NNP	I-NP	O
45005	45005	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
4/4/05	4/4/05	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CINCOTTA	CINCOTTA	NNP	B-NP	O
,	,	,	O	O
SHIRLEY	SHIRLEY	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PH	M.PH	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
17	17	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
7	7	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
SC	SC	NNP	I-NP	O
17	17	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
7	7	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
AFRIN	AFRIN	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OXYMETAZOLINE	OXYMETAZOLINE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
BID	BID	NN	I-NP	O
X	X	SYM	O	O
3	3	CD	B-NP	O
DAYS	DAYS	NN	I-NP	O
.	.	.	O	O

SALINE	SALINE	NNP	B-NP	O
NASAL	NASAL	NNP	I-NP	O
DROP	DROP	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
0.65	0.65	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
QID	QID	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
congestion	congestion	NN	B-NP	O
MVI	MVI	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
W/MINERALS	W/MINERALS	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
THERAP	THERAP	NN	I-NP	I-protein
VITS/MINERALS	VITS/MINERALS	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/12/05	6/12/05	CD	B-NP	O
by	by	IN	B-PP	O
GRAMBLING	GRAMBLING	NNP	B-NP	O
,	,	,	O	O
JOAN	JOAN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
TOPROL	TOPROL	NNP	B-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
SUDAFED	SUDAFED	NN	I-NP	O
12HR	12HR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PSEUDOEPHEDRINE	PSEUDOEPHEDRINE	NN	I-NP	O
CONTROLLED	CONTROLLED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
120	120	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
X	X	SYM	O	O
5	5	CD	B-NP	O
Days	Day	NNPS	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/27	8/27	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
TRAVATAN	TRAVATAN	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
DROP	DROP	NNP	I-NP	O
OS	OS	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
GLUCOPHAGE	GLUCOPHAGE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
M	M	NNP	B-NP	O
,	,	,	O	O
W	W	NNP	B-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
SMC	SMC	NNP	B-NP	B-cell_type
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/05	4/4/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/05	4/4/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
NTG	NTG	NNP	B-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	SYM	O	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	NN	I-NP	O
3	3	CD	I-NP	O
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
PRINIVIL	PRINIVIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/05	4/4/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Rimi	Rimi	NNP	I-NP	O
GONH	GONH	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
9/26	9/26	CD	I-NP	O
@	@	NN	I-NP	O
3	3	CD	I-NP	O
:	:	:	O	O
OO	OO	NNP	B-NP	O
,	,	,	O	O
Trey	Trey	NNP	B-NP	O
Mione	Mione	NNP	I-NP	O
,	,	,	O	O
Heart	Heart	NNP	B-NP	O
Failure	Failure	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
6/10	6/10	CD	I-NP	O
3	3	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
,	,	,	O	O
Please	Please	NNP	B-NP	O
call	call	VBP	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Florentino	Florentino	NNP	I-NP	O
Depeyster	Depeyster	NNP	I-NP	O
at	at	IN	B-PP	O
039-178-5937	039-178-5937	CD	B-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
office	office	NN	I-NP	O
will	will	MD	B-VP	O
re-open	re-open	VB	I-VP	O
on	on	IN	B-PP	O
2/5/06	2/5/06	CD	B-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
,	,	,	O	O
URI	URI	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
25-30	25-30	CD	I-NP	O
%	%	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
ID/HPI	ID/HPI	NN	B-NP	O
:	:	:	O	O
82F	82F	NN	B-NP	O
w	w	NN	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
h/o	h/o	NN	I-NP	O
ischemic	ischemic	JJ	I-NP	O
CMP	CMP	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
25-30	25-30	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
stent	stent	NN	I-NP	O
&	&	CC	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
X	X	SYM	O	O
6-8	6-8	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
increased	increase	VBN	B-NP	O
DOE	DOE	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
SOB	SOB	NN	B-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Sh	Sh	NNP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
she	she	PRP	B-NP	O
believes	believe	VBZ	B-VP	O
was	be	VBD	B-VP	O
2/2	2/2	CD	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
admits	admit	VBZ	B-VP	O
to	to	TO	B-PP	O
nasal	nasal	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
month	month	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
nonproductive	nonproductive	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
syncope	syncope	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
known	know	VBN	B-VP	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
weight	weight	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	I-NP	O
chills	chill	NNS	I-NP	O
or	or	CC	I-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
cahnge	cahnge	NN	I-NP	O
in	in	IN	B-PP	O
medications	medication	NNS	B-NP	O
,	,	,	O	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
,	,	,	O	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
dehydration	dehydration	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
her	her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
Afeb	Afeb	NN	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
bp	bp	NN	B-NP	O
100/60	100/60	CD	I-NP	O
,	,	,	O	O
SaO2	SaO2	NN	B-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
:	:	:	O	O
a	a	DT	B-NP	O
well-appearing	well-appearing	JJ	I-NP	O
woman	woman	NN	I-NP	O
,	,	,	O	O
crackles	crackle	NNS	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
bases	base	NNS	I-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	O
15cm	15cm	NN	I-NP	O
,	,	,	O	O
Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
had	have	VBD	B-VP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
lasix	lasix	NN	B-NP	O
120iv	120iv	CD	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
100iv	100iv	NN	B-NP	O
with	with	IN	B-PP	O
400cc	400cc	NN	B-NP	O
+	+	SYM	B-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
Cr	Cr	NNP	B-NP	O
1.1	1.1	CD	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
473	473	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
one	one	CD	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
ezymes	ezyme	NNS	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
old	old	JJ	B-NP	O
LBBB/LAFB	LBBB/LAFB	NN	I-NP	O
.	.	.	O	O

prolonged	prolong	VBN	B-NP	O
QTc	QTc	NN	I-NP	B-protein
CXR	CXR	NN	I-NP	I-protein
:	:	:	O	O
b/l	b/l	NN	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
calcified	calcify	VBN	B-VP	O
aortic	aortic	JJ	B-NP	O
knowb	knowb	NN	I-NP	O
,	,	,	O	O
prominent	prominent	JJ	B-NP	O
vasculature	vasculature	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
interstitial	interstitial	JJ	I-NP	O
markings	marking	NNS	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
initial	initial	JJ	I-NP	O
precipitant	precipitant	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
ISCHEMIA	ISCHEMIA	NN	B-NP	O
-	-	HYPH	B-NP	O
Patient	Patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
axis	axis	NN	B-NP	O
deviation	deviation	NN	I-NP	O
and	and	CC	I-NP	O
LBBB	LBBB	NN	I-NP	B-protein
,	,	,	O	O
findings	finding	NNS	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
EKG	EKG	NN	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
findings	finding	NNS	I-NP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
ASA	ASA	NNP	B-NP	O
325mg	325mg	CD	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
qd	qd	NN	I-NP	O
and	and	CC	I-NP	O
Simvastatin	Simvastatin	NN	I-NP	O
20mg	20mg	NN	I-NP	O
po	po	NN	I-NP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Patient	Patient	NN	I-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
25-30	25-30	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
history	history	NN	I-NP	O
and	and	CC	I-NP	O
exam	exam	NN	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
473	473	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
wt	wt	NN	I-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
d/c	d/c	NN	I-NP	O
summary	summary	NN	I-NP	O
was	be	VBD	B-VP	O
66kg	66kg	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	JJ	I-NP	O
total	total	JJ	I-NP	O
body	body	NN	I-NP	O
balance	balance	NN	I-NP	O
was	be	VBD	B-VP	O
neg	neg	NN	B-NP	O
1	1	CD	I-NP	O
liters	liter	NNS	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Lasix	Lasix	NNP	B-NP	O
200po	200po	CD	I-NP	O
qd	qd	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	CD	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
63	63	CD	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
improved	improve	VBD	B-VP	O
clinically	clinically	RB	B-ADVP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
CAD	CAD	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Antwan	Antwan	NNP	B-NP	O
Heinsohn	Heinsohn	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
clinic	clinic	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Landrey	Landrey	NNP	I-NP	O
in	in	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
.	.	.	O	O

RHYTHM	RHYTHM	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
NSR	NSR	NN	I-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
LBBB	LBBB	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regiment	regiment	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
17/7	17/7	CD	I-NP	I-protein
,	,	,	O	O
Metformin	Metformin	NN	B-NP	O
500mg	500mg	CD	I-NP	O
bid	bid	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
given	give	VBN	B-PP	O
CrCl	CrCl	NN	B-NP	O
33	33	CD	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Novolog	Novolog	NNP	I-NP	O
SS	SS	NNP	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O

FSBS	FSBS	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Metformin	Metformin	NN	I-NP	O
and	and	CC	I-NP	O
home	home	NN	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
in-patient	in-patient	JJ	I-NP	O
team	team	NN	I-NP	O
reccomends	reccomend	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
be	be	VB	B-VP	O
re-examined	re-examine	VBN	I-VP	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
reduced	reduce	VBN	I-NP	O
CrCl	CrCl	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
WBC	WBC	NN	B-NP	O
mildy	mildy	JJ	I-NP	O
elevated	elevate	VBN	B-VP	O
at	at	IN	B-PP	O
10.7	10.7	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
was	be	VBD	B-VP	O
dirty	dirty	JJ	B-ADJP	O
and	and	CC	O	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
discharged	discharge	VBD	B-VP	O
with	with	IN	B-PP	O
decongestants	decongestant	NNS	B-NP	O
and	and	CC	O	O
nasal	nasal	JJ	B-NP	O
steroid	steroid	NN	I-NP	O
spray	spray	NN	I-NP	O
for	for	IN	B-PP	O
URI	URI	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
besides	besides	IN	B-PP	O
URI	URI	NN	B-NP	O
sxs	sx	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
FEN	FEN	NN	I-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
salt	salt	NN	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
,	,	,	I-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
fluid	fluid	NN	I-NP	O
restricted	restrict	VBN	B-VP	O
to	to	TO	B-PP	O
2L/day	2L/day	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
diureses	diures	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
replaced	replace	VBN	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PROPHYLAXIS	PROPHYLAXIS	NN	I-NP	O
:	:	:	O	O
Lovenox	Lovenox	NN	B-NP	O
40mg/Esomeprazole	40mg/Esomeprazole	NN	I-NP	O
40mg	40mg	CD	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FULL	FULL	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
increase	increase	VB	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Start	Start	NNP	B-NP	O
Toprol	Toprol	NNP	I-NP	O
XL	XL	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
Sudafed	Sudafe	VBN	I-VP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
use	use	VB	B-VP	O
Afrin	Afrin	NN	B-NP	O
spray	spray	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

Use	Use	NN	B-NP	O
saline	saline	NN	I-NP	O
spray	spray	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

Followup	Followup	NNP	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rutland	Rutland	NNP	I-NP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Lincoln	Lincoln	NNP	B-NP	O
Pasquino	Pasquino	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
clinic	clinic	NN	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Vanostrand	Vanostrand	NNP	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
clinic	clinic	NN	I-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GEHRLEIN	GEHRLEIN	NNP	B-NP	O
,	,	,	O	O
BARRY	BARRY	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EI26	EI26	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/4/05	4/4/05	CD	I-NP	O
@	@	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
26	26	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

